Soliton Completes Clinical Trials for Initial FDA Filing for Tattoo Indication
Houston, TX – March 19, 2019 – Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), completed the human trials of its proprietary Rapid Acoustic Pulse (RAP) Device to […]
Why the FDA Commissioner Pushed To Shorten Medical Device Approval Process
Palm Beach, FL – March 19, 2019 – We all know the FDA is the arm of the U.S. government that, among other things, controls and oversees the approval process for medical device products and technologies are used in the diagnosis, prevention and treatment of diseases. It is estimated that presently bringing a device to […]
Image Protect Announces Upcoming Launch of World’s Largest Digital Image Monetization Platform
San Clemente, CA – March 19, 2019 – Image Protect Inc. (OTC:IMTL) (imageprotect.com) (“Image Protect” or the “Company”), a global leader in the end-to-end copyright infringement sector, is excited to announce the upcoming launch of its new Fotofy Digital Image Marketplace, which will allow users to capture images free of charge, while allowing revenue participation […]
Estimated Revenues Continue to Rise For U.S. And Global Medical Device Markets
Palm Beach, FL – March 19, 2019 – The U.S. medical device industry has seen its revenues continue to increase and it is poised is to become the global leader of this expanding market. It seems as though each new projection breaks through the ceiling of the previous projection. Here are some of the estimated […]
Soliton Completes Clinical Trials for Initial FDA Filing for Tattoo Indication
Houston, TX – March 19, 2019 – Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), completed the human trials of its proprietary Rapid Acoustic Pulse (RAP) Device to […]
Clinical Trials For Leukemia Exhibiting Encouraging Advancements
Palm Beach, FL – March 19, 2019 – Recent developments mentioned in industry sourced article from Medicalexpress.com, a research and technology news service, it was encouraging to see an optimistic headline in cancer treatments. One article stressed the need for more clinical trials. It read: “Advances in treatment for blood cancers depend on clinical trials […]
Moleculin Announces First Patients Enrolled in Lymphoma Clinical Trial
Houston, TX – March 19, 2019 – Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that the first two patients have been enrolled in its European clinical trial of WP1220 for the topical treatment of cutaneous […]
Farm Bill Passing Opens Up Ancillary Markets for CBD Sector
New York, NY – March 19, 2019 – Last year was a banner year for cannabis, as California became the largest legal US marketplace, Canada rolled out broad legalization, and Mexico’s Supreme Court opened the door to being the next country to follow. With even more new markets set to come, there also come new […]
